142 related articles for article (PubMed ID: 19772496)
1. [Oxidized fibrinogen and its relationship with hemostasis disturbances and endothelial dysfunction during coronary heart disease and myocardial infarction].
Ragino IuI; Baum VA; Polonskaia IaV; Baum SR; Nikitin IuP
Kardiologiia; 2009; 49(9):4-8. PubMed ID: 19772496
[TBL] [Abstract][Full Text] [Related]
2. Relationship between oxidized fibrinogen and hemostasis disturbances and endothelial dysfunction in myocardial infarction.
Ragino YI; Baum VA; Polonskaya YV; Sadovski EV; Baum SR; Nikitin YP
Bull Exp Biol Med; 2008 Apr; 145(4):412-4. PubMed ID: 19110580
[TBL] [Abstract][Full Text] [Related]
3. [Laboratory signs of activation of the hemostasis system in patients with coronary heart disease, who had coronary artery bypass surgery.].
Lisyutenko NS; Morova NA; Tsekhanovich VN
Klin Lab Diagn; 2018; 63(8):500-505. PubMed ID: 30726655
[TBL] [Abstract][Full Text] [Related]
4. High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: Relationship to thrombogenesis and endothelial damage/dysfunction.
Lee KW; Blann AD; Lip GY
Am J Hypertens; 2005 Jan; 18(1):104-15. PubMed ID: 15691624
[TBL] [Abstract][Full Text] [Related]
5. [Thrombocyte aggregation, endothelial dysfunction and acute myocardial infarction].
Pavlović P; Tavcioski D; Stamenković E
Vojnosanit Pregl; 2009 Apr; 66(4):323-7. PubMed ID: 19432300
[No Abstract] [Full Text] [Related]
6. Oxidative modification of fibrinogen is associated with altered function and structure in the subacute phase of myocardial infarction.
Becatti M; Marcucci R; Bruschi G; Taddei N; Bani D; Gori AM; Giusti B; Gensini GF; Abbate R; Fiorillo C
Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1355-61. PubMed ID: 24790138
[TBL] [Abstract][Full Text] [Related]
7. Atherosclerosis, myocardial infarction and primary hemostasis: Impact of platelets, von Willebrand factor and soluble glycoprotein VI.
Villmann JM; Burkhardt R; Teren A; Villmann T; Thiery J; Drogies T
Thromb Res; 2019 Aug; 180():98-104. PubMed ID: 31276978
[TBL] [Abstract][Full Text] [Related]
8. [Assessment of hemostasis in patients with myocardial infarction complicated by deep venous thrombosis].
Lewandowski K; Psuja P; Zozulińska M; Turowiecka Z; Zawilska K
Pol Arch Med Wewn; 1990 Aug; 84(2):79-85. PubMed ID: 2277786
[TBL] [Abstract][Full Text] [Related]
9. Fibrinogen and mechanisms of thrombosis. A difficult link.
Di Minno G; Cerbone A; Margaglione M; Vecchione G; Grandone E; Mancini M
Eur J Epidemiol; 1992 May; 8 Suppl 1():88-91. PubMed ID: 1505658
[TBL] [Abstract][Full Text] [Related]
10. Low Self-rated Health Is Related to Blood Hypercoagulability in Patients Admitted with Acute Myocardial Infarction.
von Känel R; Meister-Langraf RE; Schmid JP; Barth J; Znoj H; Schnyder U; Princip M
Thromb Haemost; 2018 Jan; 118(1):54-62. PubMed ID: 29304525
[TBL] [Abstract][Full Text] [Related]
11. [Procedure for determination of oxidative modification of plasma fibrinogen].
Ragino IuI; Baum VA; Polonskaia IaV; Gromov AA
Klin Lab Diagn; 2007 Jan; (1):13-6. PubMed ID: 17385436
[TBL] [Abstract][Full Text] [Related]
12. [Myocardial necrosis in coronary disease].
Baroldi G
G Ital Cardiol; 1974; 4(5):521-6. PubMed ID: 4435321
[No Abstract] [Full Text] [Related]
13. Blood coagulation system pathophysiology in acute myocardial infarction: the influence of anticoagulant treatment on laboratory findings.
Fletcher AP; Alkjaersig NK; Ghani FM; Tulevski V; Owens O
J Lab Clin Med; 1979 Jun; 93(6):1054-65. PubMed ID: 438607
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.
Chiang KH; Huang PH; Huang SS; Wu TC; Chen JW; Lin SJ
Coron Artery Dis; 2009 Jun; 20(4):267-73. PubMed ID: 19440065
[TBL] [Abstract][Full Text] [Related]
15. Predicting the severity of systemic inflammatory response syndrome (SIRS)-associated coagulopathy with hemostatic molecular markers and vascular endothelial injury markers.
Iba T; Gando S; Murata A; Kushimoto S; Saitoh D; Eguchi Y; Ohtomo Y; Okamoto K; Koseki K; Mayumi T; Ikeda T; Ishhikura H; Ueyama M; Ogura Y; Endo S; Shimazaki S;
J Trauma; 2007 Nov; 63(5):1093-8. PubMed ID: 17993956
[TBL] [Abstract][Full Text] [Related]
16. [Endogenous sex hormone testosterone and haemostatic factors in young men after myocardial infarction].
Kerimova KN; Bakhshaliev AB; Gadzhiev RF; Gamidova ÉS
Kardiologiia; 2012; 52(6):24-7. PubMed ID: 22839666
[TBL] [Abstract][Full Text] [Related]
17. [Determination of fibrinogen and fibrin degradation products (DFP) in the acute stage of myocardial infarction].
Baele G; Mussche M; Vermeire P; Pannier R
Arch Mal Coeur Vaiss; 1973 Apr; 66(4):427-9. PubMed ID: 4198846
[No Abstract] [Full Text] [Related]
18. Platelet and leukocyte activation after myocardial infarction. Influence of enalapril.
Sylvén C; Hagerman I; Karlberg KE; Chen J; Wallin R; Eneroth P; Bergström K; Saldeen T
Eur Heart J; 1995 Dec; 16(12):1800-6. PubMed ID: 8682010
[TBL] [Abstract][Full Text] [Related]
19. D-dimers in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction.
Tataru MC; Heinrich J; Junker R; Schulte H; von Eckardstein A; Assmann G; Koehler E
Eur Heart J; 1999 Oct; 20(20):1493-502. PubMed ID: 10493848
[TBL] [Abstract][Full Text] [Related]
20. [State of hemostasis and blood rheology in congestive circulatory insufficiency].
Liusov VA; Belousov IuB; Savenkov MP; Sidorskiĭ AL; Panchenko EP
Kardiologiia; 1979 Apr; 19(4):86-93. PubMed ID: 439614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
